Latest Juvenile Diabetes Research Foundation Stories

Doctors have tricked mouse immune systems into thinking cells from a donor pancreas are theirs, bringing hope to diabetes patients, U.S. researchers said. The new technique, to fight type 1 diabetes, eliminated the need for drugs that inhibit immune-system activity in diabetic mice that had insulin-producing islet cell transplantation, Northwestern University Feinberg School of Medicine researchers said. Immunosuppressive drugs prevent bodies from rejecting the islet cells, but they're toxic...

NEW YORK, Nov. 14 /PRNewswire/ -- Data from a new global survey released on World Diabetes Day finds that many teens and young adults with type 1 diabetes are optimistic about their future, but report a lack of support from school staff. The poll highlights the importance of family and peer-to-peer support. The DAWN Youth WebTalk Survey was conducted in partnership with the International Diabetes Federation and the International Society for Pediatric and Adolescent Diabetes as part of DAWN...

Bayhill Therapeutics, a biopharmaceutical company, and the Juvenile Diabetes Research Foundation have announced a partnership to support Bayhill's ongoing Phase I/II human clinical trial of BHT-3021, a DNA vaccine to reverse the immune response that causes Type 1 diabetes. The agreement with Bayhill is a part of Juvenile Diabetes Research Foundation's (JDRF's) innovative industry discovery and development partnership (IDDP) program, through which JDRF partners with pharmaceutical, biotech,...

TARRYTOWN, N.Y., Oct. 30 /PRNewswire/ -- To kick off Diabetes Awareness Month, Bayer Diabetes Care announced that four people with diabetes have won the opportunity to meet teen pop sensation Nick Jonas of the Jonas Brothers after entering the national "Walk In Nick's Shoes" (W.I.N.S.) sweepstakes. These Grand Prize winners will meet Nick Jonas in Los Angeles and walk as "Team Jonas" at the Juvenile Diabetes Research Foundation (JDRF) Walk for the Cure in Los Angeles on November 1. The...

Bayhill Therapeutics, Inc., a leading developer of therapies for autoimmune diseases, and the Juvenile Diabetes Research Foundation, the world's leading charitable funder of type 1 diabetes research, today announced a partnership to support Bayhill's ongoing Phase I/II human clinical trial of BHT-3021, a DNA vaccine to reverse the immune response that causes type 1 diabetes. BHT-3021 is an antigen-specific immunotherapeutic DNA vaccine designed to reverse the underlying autoimmune disease...

SmartCells, a provider of polymer-based dosing technology, and the Juvenile Diabetes Research Foundation have announced a partnership to advance SmartCells's SmartInsulin for the treatment of type 1 diabetes. As part of the agreement, the Juvenile Diabetes Research Foundation (JDRF) will provide $1 million in first-year funding to support preclinical safety and efficacy testing. The partnership is structured to support milestone-based funding through proof-of-concept human clinical trials....

SmartCells, Inc. and the Juvenile Diabetes Research Foundation (JDRF) today announced a partnership to advance SmartCells' SmartInsulin(TM) for the treatment of type 1 diabetes. SmartInsulin will be a once-a-day, glucose-regulated subcutaneous insulin formulation for treating diabetes. SmartInsulin is injectable, like today's currently available insulins, but designed to maintain continuous, tight control of blood glucose levels while reducing the risk of hypoglycemia - like the pancreas does...

Genetics researchers have identified two novel gene locations that raise the risk of type 1 diabetes. As they continue to reveal pieces of the complicated genetic puzzle for this disease, the researchers expect to improve predictive tests and devise preventive strategies."As we add to our knowledge of the biology of type 1 diabetes and better understand details of the disease's genetic risk, we will be able to develop better diagnostic tests that meaningfully predict who will develop...

PPD, Inc. (Nasdaq: PPDI) today announced it has been selected as a full-service preferred provider for translational clinical development services by the Juvenile Diabetes Research Foundation (JDRF) and will share its expertise with academic investigators who are conducting JDRF-funded, early phase clinical trials for type 1 diabetes and its complications. JDRF is the world's largest charitable funder of type 1 diabetes research. Last year, the foundation funded more than 1,000 grants in...

Sisters Hannah and Emma Fullalove have taken part in a sponsored walk at Saltram to raise money for the Juvenile Diabetes Research Foundation. The girls, both pupils at Plymouth College Preparatory School, have friends with Type 1 diabetes, and after seeing their struggle with special foods and insulin injections, they wanted to do their bit to help fund research into a cure. Instead of sponsorship money, the girls, aged 10 and eight respectively, asked their school friends for donations in...